Search
Press Releases
Search Archive:  

 

India to Emerge as Vaccine Manufacturing Hub

Feb 25, 2010
Share |
 

India has emerged as a new hub for vaccine manufacturers from all over the world. There are many factors like low cost manufacturing, large pool of talented and skilled manpower, low manpower cost and strong government support which have supported the country to catch the attention of vaccine manufacturers to invest in this lucrative market. Moreover, rising prevalence of diseases has given strong boost to the sales of vaccines in the country itself. According to our new research "Global Vaccine Market Forecast to 2012", the vaccine market in India is forecasted to grow at a CAGR of around 23% from 2009-10 to 2011-12.

Our research has found that focus of vaccine majors has shifted towards developing countries like China, India and Brazil. Most of the investments at the global level are being done in these countries to tap the benefits offered by them and expand business operations. In this regard, our research encapsulates details of country level markets. The report also provides information about the key players existing in these markets along with the information of their business revenues and product portfolio. The research also envisages the key strategies adopted by these players to provide a comprehensive overview of the market.

Our research has studied various segments of the global vaccine market and found that pediatrics will grow more than adult vaccines. We have found that among the highest selling pediatrics vaccines, polio, tuberculosis and pneumococcal will see strong demand. Among adult vaccines, influenza is expected to be the highest selling vaccine. Besides, the report contains an exhaustive information about vaccine players at the global level along with their sales revenues.

"Global Vaccine Market Forecast to 2012" analyzes key segments of the vaccine industry to give qualitative information, quantitative data and comparable statistics to help clients under the market dynamics and trends. The report also provides forecast for different segments after thorough study of the present and past market trends in view of recent breakout of diseases and their fast spreading across the globe. The report will help clients in understanding the market in a better way and provide an additional edge over other competitors to devise their future strategy.

For more information visit: http://www.rncos.com/Report/IM153.htm


Related Press Releases:
» Giant Leap in Global Cancer Vaccines Market
» Global Influenza Vaccine Market to Cross US$ 4 Billion Mark by 2011 End
» India and China to Drive Global Vaccine Market
» Emerging Countries Boosting Global Vaccine Market
» Seasonal Influenza Vaccine Market Set to Grow in Near Future
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL | FAQ | Upcoming Reports
Copyright © 2012, RNCOS, 2002-2012
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707